Cogent Biosciences公司——根据其向美国证券交易委员会提交的文件显示,该公司可能通过Guggenheim Securities进行高达4亿美元的普通股公开发售。这一动向,无疑为市场注入了新的关注点。
Cogent Biosciences公司——根据其向美国证券交易委员会提交的文件显示,该公司可能通过Guggenheim Securities进行高达4亿美元的普通股公开发售。这一动向,无疑为市场注入了新的关注点。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.